Natural Alternatives International (NAII) Competitors $3.55 -0.04 (-1.11%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. BYSI, PMVP, IGMS, ASRT, UNCY, IZTC, CNTX, RPTX, SLGL, and ELYMShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include BeyondSpring (BYSI), PMV Pharmaceuticals (PMVP), IGM Biosciences (IGMS), Assertio (ASRT), Unicycive Therapeutics (UNCY), Invizyne Technologies (IZTC), Context Therapeutics (CNTX), Repare Therapeutics (RPTX), Sol-Gel Technologies (SLGL), and Eliem Therapeutics (ELYM). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors BeyondSpring PMV Pharmaceuticals IGM Biosciences Assertio Unicycive Therapeutics Invizyne Technologies Context Therapeutics Repare Therapeutics Sol-Gel Technologies Eliem Therapeutics BeyondSpring (NASDAQ:BYSI) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings. Which has preferable earnings and valuation, BYSI or NAII? Natural Alternatives International has higher revenue and earnings than BeyondSpring. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyondSpringN/AN/A-$11.12MN/AN/ANatural Alternatives International$113.80M0.19-$7.22M-$1.39-2.52 Does the media prefer BYSI or NAII? In the previous week, BeyondSpring and BeyondSpring both had 2 articles in the media. Natural Alternatives International's average media sentiment score of 1.46 beat BeyondSpring's score of 0.95 indicating that Natural Alternatives International is being referred to more favorably in the news media. Company Overall Sentiment BeyondSpring Positive Natural Alternatives International Positive Which has more volatility and risk, BYSI or NAII? BeyondSpring has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Do institutionals and insiders hold more shares of BYSI or NAII? 40.3% of BeyondSpring shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 29.3% of BeyondSpring shares are held by insiders. Comparatively, 20.9% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is BYSI or NAII more profitable? BeyondSpring has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. BeyondSpring's return on equity of 0.00% beat Natural Alternatives International's return on equity.Company Net Margins Return on Equity Return on Assets BeyondSpringN/A N/A N/A Natural Alternatives International -6.56%-10.34%-5.19% SummaryBeyondSpring beats Natural Alternatives International on 5 of the 9 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.18M$2.59B$5.86B$10.15BDividend YieldN/A56.51%5.68%4.59%P/E Ratio-2.5223.5374.5225.93Price / Sales0.19702.37540.10123.77Price / CashN/A171.1637.5660.44Price / Book0.265.3712.166.29Net Income-$7.22M$32.95M$3.28B$270.77M7 Day Performance-2.78%1.31%0.98%3.36%1 Month Performance-7.77%8.31%7.20%6.41%1 Year Performance-44.00%0.29%63.06%28.26% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International1.6504 of 5 stars$3.50-2.5%N/A-43.7%$22.18M$113.80M-2.52290Positive NewsShort Interest ↓BYSIBeyondSpringN/A$1.99+4.5%N/A-13.4%$80.06M$1.75M0.0080Gap DownPMVPPMV Pharmaceuticals2.8446 of 5 stars$1.48+5.4%$5.50+272.9%-18.5%$77.90MN/A-0.9450News CoveragePositive NewsInsider TradeHigh Trading VolumeIGMSIGM Biosciences4.0669 of 5 stars$1.27flat$4.89+285.0%N/A$76.57M$145.05M-1.41190ASRTAssertio1.7562 of 5 stars$0.79-1.5%$2.38+199.5%-36.6%$76.32M$124.96M-1.7620UNCYUnicycive Therapeutics2.1038 of 5 stars$4.29-1.9%$60.00+1,300.2%+2.3%$75.69M$680K-1.049IZTCInvizyne TechnologiesN/A$12.00+0.3%N/AN/A$75.02MN/A0.0029News CoverageCNTXContext Therapeutics3.5152 of 5 stars$0.84+1.7%$5.25+528.7%-60.9%$74.90MN/A-2.327News CoverageShort Interest ↓RPTXRepare Therapeutics2.8554 of 5 stars$1.74+1.8%$4.50+158.6%-35.6%$74.75M$53.48M-0.67180Positive NewsSLGLSol-Gel Technologies0.7687 of 5 stars$26.45-4.0%N/A+267.6%$73.80M$11.54M-21.5050Short Interest ↑ELYMEliem TherapeuticsN/A$2.47+3.3%N/A-69.8%$73.49MN/A-4.669Gap Up Related Companies and Tools Related Companies BeyondSpring Competitors PMV Pharmaceuticals Competitors IGM Biosciences Competitors Assertio Competitors Unicycive Therapeutics Competitors Invizyne Technologies Competitors Context Therapeutics Competitors Repare Therapeutics Competitors Sol-Gel Technologies Competitors Eliem Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.